There has been progress towards decreasing malaria prevalence globally; however,
Plasmodiumávivax has been less responsive to elimination efforts compared with …

A randomized, double-blind, controlled vaccine clinical trial was conducted to assess, as the
primary outcome, the safety and protective efficacy of the Plasmodium vivax …

Simple Summary Alteration of platelet count is frequently seen in patients with malaria.
However, the platelet biology under severe pathological conditions like severe malaria …

Background Pregnant women are particularly vulnerable to malaria infections, increasing
the risk of maternal–fetal complications, mainly in high-endemicity areas. However, few …

Plasmodium vivax has high morbidity, it is the Plasmodium species with the greatest
worldwide distribution, and its ability to trigger severe symptoms is currently recognized. The …

Clinical immunity to malaria is associated with the acquisition of IgG specific for members of
the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family of clonally …

Early and accurate diagnosis is critical in reducing the morbidity and mortality associated
with malaria. Microscopy (MI) is the current diagnostic gold standard in the field; however, it …

Introducción: La malaria es un problema de salud pública para Colombia, con
comportamiento endémico/epidémico y variación entre las diferentes áreas de transmisión …

The extent of abnormalities in blood indices and their subsequent effects on clinical severity
in malaria differ among populations of different endemicity. However, these alterations have …

Malaria caused by Plasmodium vivax is a neglected disease which is responsible for the
highest morbidity in both Americas and Asia. Despite continuous public health efforts to …